Asia Pacific Metabolic Testing Market is expected to grow to USD 98 million in 2

Posted by rohan on November 16th, 2017

According to the Asia Pacific Metabolic Testing Market Forecast Report, the market worth USD 69million in 2016 and estimated to grow at a CAGR of 7.2%, to reach USD 98million by 2021. The Asia Pacific Metabolic Testing market is developing at an exceptionally quick pace.

Browse Market data tables and in-depth TOC of the Asia Pacific Metabolic Testing Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-metabolic-testing-market-4381/

Metabolism is a chemical reaction and physical process that involves maintenance of the living state, such as breathing, blood circulation, contraction of muscles, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, and functioning of brain and nerves of the organism. It is a pathway that begins with a sequence of chemical reactions with a specific molecule and ends with a product with the help of specific enzyme. Enzymes are vital to metabolism as they allow the organism to drive reactions for required energy. It is divided into two categories, i.e. catabolism and anabolism. A comprehensive metabolic panel is a blood test that measures your sugar (glucose) level, electrolyte and fluid balance, kidney function, and liver function.

The significant driver is rising prevalence of lifestyle based diseases coupled with increasing geriatric population with high susceptibility towards developing chronic diseases such as cancer and kidney disorders. Also surge in technological advancements such as the introduction of digital metabolic rate testing equipment and rapidly increasing healthcare expenditure levels in developed and developing nations is boosting the industry.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-metabolic-testing-market-4381/request-sample

The Asia Pacific Metabolic Testing Market Segmentation, on the basis of product, application, technology, End user and region. Based on product, the market is segmented into CPET, Body Composition Analysis, ECG, Software and Portable System. Based on application, the market is segmented into critical care, dysmetabolic syndrome X, human performance testing, lifestyle diseases and other metabolic disorders. Based on technology the market is segmented into RMR analysis, VO2 max analysis and body composition analysis. The VO2 max analysis segment attributes the largest share of the market. It directly measures the body oxygen consumption, which other tests try to estimate. Based on End user, the market is segmented into laboratories, hospitals, gyms and sports training centers.

Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. China and India are likely to increase the market because of huge population. Also Asia Pacific is largest growing segment.

Metabolic Testing Market Leaders are, Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail:abhishek@marketdataforecast.com